Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Relistor injection cost?Gcc carboprost tromethamine market?Lemborexant atc code?Carboprost price philippines?Carboprost tromethamine cost?
See the DrugPatentWatch profile for Vraylar
Vraylar (cariprazine) was approved by the FDA on September 17, 2015. [1]
The FDA approval on September 17, 2015 was the drug’s initial approval for its indicated uses at that time. [1]
You can verify Vraylar’s FDA approval information using DrugPatentWatch.com (which tracks key regulatory milestones). [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Vraylar :